(3.237.66.86)
Users online: 3032    [ij] [ij] [ij] 
Email id
 

Asian Journal of Pharmaceutical Analysis
Year : 2018, Volume : 8, Issue : 3
First page : ( 125) Last page : ( 128)
Print ISSN : 2231-5667. Online ISSN : 2231-5675.
Article DOI : 10.5958/2231-5675.2018.00023.6

UV Spectroscopic Degradation Study of Pioglitazone Hydrochloride

Patil Omkar A.*, Patil Indrajeet S., Vambhurkar Ganesh B., Randive Dheeraj S., Dr. Bhutkar Mangesh A., Dr. Mohite Srinivas K.

Department of Pharmaceutics, Rajarambapu College of Pharmacy, Kasegaon, Maharashtra, India-415404

*Corresponding Author E-mail: omkarpatil3332@gmail.com

Online published on 24 October, 2018.

Abstract

Pioglitazone is an antidiabetic agent from thiazolidinedione class which is used in the treatment of Type 2 diabetes mellitus. It activates PPAR-γ found in adipose tissue, pancreatic β-cells, vascular endothelium and macro-phages. Degradation is a main problem in numerous unstable products. As per the ICH guidelines factors which causes degradation of a drug product comprise of temperature, time, photo degradation, pH variation (high and low), acid/base stress testing and/or with humidity. In our research work UV-V spectroscopy method was designed to examine and calculate the quantity of drug in the presence of degradation products. WHO, the official assay limit of the content should not less than 98% and not more than 102% of labelled amount of Pioglitazone. From the results of our study it can concluded that Pioglitazone degrades most when exposed to the basic medium and heat but do not undergo degradation in acidic medium, whereas slight degradation occurs in the UV.

Top

Keywords

Pioglitazone, Degradation, Stability, Diabetes mellitus, UV Spectroscopy.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
457,893,715 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.